SCHEMBL1013903

SCHEMBL1013903

CC1CCCC2CN(C(=O)CN3CCc4cc(-c5cncnc5)ccc4C3)CCN12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 2/20 0.38
PRMT5 O14744 4/20 0.38
WDR77 Q9BQA1 4/20 0.38
MAPK1 P28482 1/20 0.36
ALDH1A1 P00352 4/20 0.36
ADAMTS5 Q9UNA0 1/20 0.36
S1PR1 P21453 2/20 0.36
CD274 Q9NZQ7 1/20 0.34
PKM P14618 2/20 0.34
GAA P10253 2/20 0.34
HSD17B10 Q99714 1/20 0.34
CHRM2 P08172 2/20 0.33
CHRM4 P08173 2/20 0.33
CHRM1 P11229 2/20 0.33
ITK Q08881 1/20 0.33
ACACB O00763 1/20 0.33
CHRM3 P20309 1/20 0.33
KMT2A Q03164 2/20 0.33
KDM4E B2RXH2 1/20 0.33
MEN1 O00255 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12707069 1.00 HRH3 (0.38) HRH3PRMT5WDR77MAPK1ALDH1A1
SCHEMBL1014615 0.92 ALDH1A1 (0.39) HRH3PRMT5WDR77MAPK1ALDH1A1
SCHEMBL1016362 0.92 ALDH1A1 (0.39) HRH3PRMT5WDR77MAPK1ALDH1A1
SCHEMBL1017021 0.91 ALDH1A1 (0.38) HRH3PRMT5WDR77MAPK1ALDH1A1
SCHEMBL1018862 0.91 ALDH1A1 (0.38) HRH3PRMT5WDR77MAPK1ALDH1A1
SCHEMBL12707105 0.90 PRMT5 (0.37) HRH3PRMT5WDR77MAPK1ALDH1A1
SCHEMBL1018350 0.90 PRMT5 (0.37) HRH3PRMT5WDR77MAPK1ALDH1A1
SCHEMBL1018729 0.87 ALDH1A1 (0.38) HRH3PRMT5WDR77MAPK1ALDH1A1
SCHEMBL1017818 0.86 PRMT5 (0.38) HRH3PRMT5WDR77MAPK1ALDH1A1
SCHEMBL1020627 0.86 PRMT5 (0.38) HRH3PRMT5WDR77MAPK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110082130-A1 PIPERAZINYL OXOALKYL TETRAHYDROISOQUINOLINES AND RELATED ANALOGUES LIGAND PHARMACEUTICALS, INC. (US) 2011-04-07 US disclosed
EP-1998620-B1 PIPERAZINYL OXOALKYL TETRAHYDROISOQUINOLINES AND RELATED ANALOGUES NEUROGEN CORP (US) 2011-01-12 EP disclosed
US-7795262-B2 Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues NEUROGEN CORPORATION (US) 2010-09-14 US disclosed
US-20070232591-A1 Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues NEUROGEN CORPORATION 2007-10-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070232591-A1 Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues HRH3, HRH4, HRH1 HRH3 1/4885PRMT5 821/4885WDR77 1697/4885
US-20110082130-A1 PIPERAZINYL OXOALKYL TETRAHYDROISOQUINOLINES AND RELATED ANALOGUES HRH3, HRH4, HRH1 HRH3 1/4885PRMT5 821/4885WDR77 1697/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.